Gadolinium phobia remains a very real danger in Europe, but practical measures can help to reduce the risk, according to Dr. Johannes Heverhagen, professor and head of radiology at the University Hospital of Bern in Switzerland. In advance of Friday’s ECR special focus session on the safety of gadolinium contrast agents for MRI, he also provides an update on the European Medicines Agency’s investigation, the results of which are expected soon.
Gadolinium phobia remains a very real danger in Europe, but practical measures can help to reduce the risk, according to Dr. Johannes Heverhagen, professor and head of radiology at the University Hospital of Bern in Switzerland. In advance of Friday’s ECR special focus session on the safety of gadolinium contrast agents for MRI, he also provides an update on the European Medicines Agency’s investigation, the results of which are expected soon.Video from ECR 2017: Dr. Johannes Heverhagen on gadolinium contrast
Mar 1, 2017
Latest in Home
‘Dark-light-dark sign’ on MRI predicts rectal cancer metastasis
December 23, 2025
CT-based model assesses lung lesions from nonsolid nodules
December 23, 2025
MRI reveals how statins reduce vessel wall inflammation
December 23, 2025
New PET tracer helps detect pulmonary sarcoidosis
December 22, 2025















